Genflow Biosciences Plc Statistics
Want to see GB:GENF full AI Analyst Report?
Genflow Biosciences Plc (GENF) Stock Statistics & Valuation Metrics
Total Valuation
Genflow Biosciences Plc has a market cap or net worth of GBX 9.81M. The enterprise value is GBX 11.17M.
- Market Cap
- GBX 9.81M
- Enterprise Value
- GBX 11.17M
Share Statistics
Genflow Biosciences Plc has 594,534,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 594,534,800
- Owned by Insiders
- 38.71%
- Owned by Institutions
- ―
Financial Efficiency
Genflow Biosciences Plc’s return on equity (ROE) is 2.57 and return on invested capital (ROIC) is 363.69%.
- Return on Equity (ROE)
- 2.57
- Return on Assets (ROA)
- -3.13
- Return on Invested Capital (ROIC)
- 363.69%
- Return on Capital Employed (ROCE)
- 3.64
- Revenue Per Employee
- 0
- Profits Per Employee
- -283.51K
- Employee Count
- 5
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Genflow Biosciences Plc is -7.50. Genflow Biosciences Plc’s PEG ratio is -0.08.
- PE Ratio
- -7.50
- PS Ratio
- 16.75
- PB Ratio
- 45.65
- Price to FCF
- -7.95
- Price to Operating Cash Flow
- -7.03
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, Genflow Biosciences Plc had revenue of 0 and earned -1.42M in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- -1,093
- Operating Income
- -2.00M
- Pretax Income
- -1.42M
- Net Income
- -1.42M
- EBITDA
- -2.00M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -1.23M and capital expenditures -652, giving a free cash flow of -1.23M billion.
- Operating Cash Flow
- -1.23M
- Free Cash Flow
- -1.23M
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Genflow Biosciences Plc pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12.58%
- Earnings Yield
- -12.69%
Stock Price Statistics
- Beta
- -0.22
- 52-Week Price Change
- -17.50%
- 50-Day Moving Average
- 1.92
- 200-Day Moving Average
- 2.02
- Relative Strength Index (RSI)
- 36.59
- Average Volume (3m)
- 2.22M
Important Dates
Genflow Biosciences Plc upcoming earnings date is Apr 28, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 29, 2026
- Next Earnings Date
- Apr 28, 2027
- Ex-Dividend Date
- ―
Financial Position
Genflow Biosciences Plc as a current ratio of 0.45, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.45
- Quick Ratio
- 0.45
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.06
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Genflow Biosciences Plc has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Genflow Biosciences Plc EV to EBITDA ratio is -8.35, with an EV/FCF ratio of -7.43.
- EV to Sales
- 15.67
- EV to EBITDA
- -8.35
- EV to Free Cash Flow
- -7.43
- EV to Operating Cash Flow
- -7.44
Balance Sheet
Genflow Biosciences Plc has GBX 632.55K in cash and marketable securities with GBX 0.00 in debt, giving a net cash position of GBX 632.55K billion.
- Cash & Marketable Securities
- GBX 632.55K
- Total Debt
- GBX 0.00
- Net Cash
- GBX 632.55K
- Net Cash Per Share
- GBX 0.00
- Tangible Book Value Per Share
- GBX 0.00
Margins
Gross margin is 100.00%, with operating margin of -214.09%, and net profit margin of -187.87%.
- Gross Margin
- 100.00%
- Operating Margin
- -214.09%
- Pretax Margin
- -187.87%
- Net Profit Margin
- -187.87%
- EBITDA Margin
- -187.65%
- EBIT Margin
- -187.78%
Analyst Forecast
The average price target for Genflow Biosciences Plc is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 56.00%
Scores
- Smart Score
- ―
- AI Score
- 42
